Prof Dr Adeeba (left) receiving the contribution from Burden during the launch of the partnership.
GLAXOSmithKline Pharmaceutical Sdn Bhd (GSK Malaysia) has earmarked RM1.25mil for the Malaysian AIDS Foundation (MAF) to advance three of its high-impact AIDS programmes over the next three years.
MAF chairman Prof Datuk Dr Adeeba Kamarulzaman received the funds on behalf of MAF from GSK Malaysia general manager and vice-president Ramil Burden at the official launch of the partnership.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
